Validity and Usefulness of the Hospital Anxiety and Depression Scale in Carers of People with Dementia: Evidence from Confirmatory Factor Analysis, Concurrent Validity, and Measurement Invariance in a Large Sample by Stott, J et al.
  1 
Word count 3498 (does not include footnote about copyright or instructions to insert 
tables) 
The validity and usefulness of the Hospital Anxiety and Depression Scale in carers of 
people with dementia: evidence from confirmatory factor analysis, concurrent validity 
and measurement invariance in a large sample. 
 
Authors: Joshua Stott, DClinPsy1* Martin Orrell, PhD2, Georgina Charlesworth, PhD1 
1 Research Department of Clinical, Educational and Health Psychology 
University College London WC1E 7HB 
2 Institute of Mental Health University of Nottingham 
*Corresponding author – address contact details as above, telephone 02076795950, email: 
j.stott@ucl.ac.uk  
 
Conflicts and interests and sources of funding  
No authors declare a conflict of interest. This analysis was completed as part of a fellowship 
awarded to Joshua Stott by the Alzheimer’s society. Grant number 236 (AS-CTF-14-005).  
This was a secondary data analysis of two grant funded trials which specify the need to state 
specific funding statements on published articles. These are included in acknowledgements.  
 
Acknowledgements 
 
CSP-RYCT funding statement 
This article presents independent research funded by the National Institute for Health 
Research [Programme Grant Reference RP-PG-0606-1083. Support at Home – Interventions 
to Enhance Life in Dementia (SHIELD)]. The views expressed are those of the author(s) and 
not necessarily those of the NHS, the NIHR or the Department of Health.  
BECCA funding statement 
  2 
The BECCA trial was commissioned by the NHS R&D Health Technology Assessment 
(HTA) Programme (project no 99/34/07) after a call for primary research into “support for 
carers” and the associated peer review process. Views and opinions expressed in this paper 
are not necessarily those of the Department of Health. 
Other acknowledgements 
The authors would like to acknowledge the investigators involved in the SHEILD trial. We 
would also like to acknowledge those involved in the BECCA trial (Professors Lee 
Shepstone, Fiona Poland, Ian Harvey, Shirley Reynolds, Miranda Mugford and David Price) 
for their generous granting of license to use their datasets.  
 
 
 
 
 
 
 
 
 
Key Words: HADS;  Hospital 
Anxiety and Depression Scale; 
validity; Carers; dementia; factor 
analysis 
  
  3 
 
ABSTRACT  
Objectives 
The Hospital Anxiety and Depression Scale (HADS) is a self-report measure of anxiety and 
depression. It is recommended for clinical assessment and has been used as the primary 
outcome in large clinical trials with carers of people with dementia. Its validity and utility 
have never been examined in this population. The current study addresses this.   
Design 
Secondary data analysis of baseline data from a recent intervention trial (N = 284) with cross-
validation in baseline data from a second trial (N=230).  
Methods 
We used confirmatory Factor Analysis to test whether a one, two or three factor structure best 
fit the data and used indices of model misspecification to re-specify. We assessed internal 
consistency, concurrent validity of obtained factors and measurement invariance across 
gender, age, kinship and cohabitation status. 
Results  
A three-factor structure best fit the data. Removal of one item improved model fit. The 
factors showed good internal consistency and high levels of concurrent validity. 
Measurement invariance was adequate across gender and kinship, but not age or cohabitation 
status. Results were replicated in the cross-validation sample, enhancing reliability.  
Conclusions 
In this group, the HADS measures three factors; depression, anxiety and negative affectivity. 
The depression scale can be used as originally intended, supporting results of large clinical 
trials. The HADS does not validly measure distress or anxiety. Consequently, clinical 
practice recommendations could be revisited and future research trials should not use HADS 
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anxiety or distress as outcomes. Researchers should pay attention to measurement invariance 
when using HADS to compare carer subgroups  
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OBJECTIVES 
Around 40% of carers of people with dementia have clinically significant anxiety, depression 
or other psychological symptoms (1). Such psychological morbidity is predictive of elder 
abuse(2) and breakdown in care with associated economic implications(3). Since there are 
clinically(4) and cost effective(5) interventions, it is important to be able to assess and detect  
anxiety and depression in this group. 
The Hospital Anxiety and Depression Scale (HADS) (6) is a 14-item self-report measure that 
is brief, measures both anxiety and depression and can be used in those with comorbid 
physical health problems (6). The HADS is recommended in European consensus guidelines 
for carers of people with dementia (7) and has been used as the primary outcome measure in 
large clinical trials in this group (4, 8). 
Despite widespread usage, there are concerns about the validity of the HADS. In particular, 
there is no consensus as to the underlying factors it measures (9). This is critical as without 
clear understanding of this ‘structural validity’, measurements cannot be adequately 
interpreted (10).   
To our knowledge, no study has examined the factor structure of the HADS in a sample 
comprised solely of carers of people with dementia. Lack of consensus as to factor structure 
in the carer literature, with some trials interpreting the HADS as measuring a single factor of 
distress (4) and others (11) as well as clinical recommendations(7) , interpreting it as a two 
factor measure of anxiety and depression. Findings from the non-carer literature cannot be 
directly applied. Multiple studies have suggested that the HADS can differ in factor structure 
across even populations that appear superficially similar (e.g. patients with different health 
conditions) (9) measuring one factor  (12) in one population and two (6) or even three factors, 
in others (9, 13).  It is also possible that the validity and utility of HADS items may vary in 
dementia carers compared to other groups, by virtue of their experience (e.g. grief) (14) and 
demographic characteristics (e.g. a high proportion of older adults) (15). In the light of such 
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issues it is recommended (9) that  HADS structure be evaluated in each population with 
which it is used, with reliability of conclusions enhanced through cross-validation in a 
separate sample (9) and validity confirmed through as expected correlations with related 
measures(16). 
Importantly, examination of HADS structure in carers specifically also allows assessment of 
measurement invariance to determine whether the HADS can be accurately used to examine 
differences between subgroups of carers (17). This is of considerable import because carers 
are a heterogeneous group and researchers are often interested in whether particular 
characteristics of carers (e.g. gender, kinship, cohabitation with person with dementia, or age) 
impact on anxiety or depression (18, 19).  
Hence, in the current study, we examine the usefulness of the HADS in a sample of carers of 
people with dementia, evaluating its factor structure to determine interpretation as an 
outcome measure or clinical tool, concurrent validity to reinforce conclusions and 
measurement invariance to inform comparisons across subgroups of carers.   
METHODS 
Design  
This is a cross-sectional, secondary data analysis of baseline data from the ‘Carer Support 
Programme/Remembering Yesterday Caring for Today (CSP-RYCT)’ trial (11) with cross-
validation in a sample comprised of baseline data from the ‘Befriending and Cost of Caring 
(BECCA)’ trial (8). 
Participants 
291 participants took part in the CSP RYCT trial (11) and 236 in the BECCA trial (8) All 
participants were  carers to at least one person diagnosed with dementia of varying subtypes 
(Alzheimer’s disease, vascular dementia and others) according to DSM-IV criteria. The 
recruitment procedures and sample for the trials have been described elsewhere (8, 11). Since 
seven individuals from the CSP RYCT trial and six from the BECCA trial did not complete 
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the HADS and this data was missing completely at random (Little’s MCAR p<0.05), their 
data were removed from analyses(20). Thus 284 participants were included in the initial 
analysis and 230 in the cross-validation analysis. Demographic and clinical characteristics for 
both samples are presented in Table 1. Ethical approval for use of CSP-RYCT data was given 
by the Outer North East London NHS Research Ethics committee (reference number: 
09/H0701/54) and for the BECCA data by the Eastern Multi Regional Ethics Committee 
(01/5/48). All participants gave written informed consent.  
Instruments 
The HADS 
The HADS comprises 14 items each rated from 0-3, with higher scores indicating greater 
anxiety/depression. The anxiety and depression subscales each have seven items, a maximum 
score of 21 and cut offs of 11 for caseness (6). While structural validity and measurement 
invariance are not clear (9), reliability and other forms of validity are well established in non-
carer populations (21). 
The PANAS 
We used the PANAS as a preliminary measure of concurrent validity as it was the best 
available measure in the dataset, having well-established patterns of association with the 
HADS in a large sample of healthy volunteers (22). It consists of two 10-item mood scales 
and was developed to provide brief measures of positive and negative affectivity(23). Items 
are rated from 1-5, score range on each scale is 5-50, with higher scores indicating greater 
positive/negative affectivity. Both PA and NA scales are internally consistent (=0.93 and 
0.91 respectively), are negatively correlated as expected and correlate with related 
measures(22).   
Statistical Analyses  
We used confirmatory factor analysis (CFA) to test the fit of the HADS data with the three 
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most commonly proposed factor structures: the original two-factor model (6), the one-factor 
model(12), and Dunbar et al.’s three-factor non-hierarchical model (24). Diagrams 
illustrating these models are shown in Figure 1. For all models, independence of error terms 
was specified, and factors were allowed to correlate. The metric of latent variables was set by 
fixing the loading of one of the indicators for each variable at 1(25). CFA was performed in 
R(version 3.2.2) (26) statistical software using Lavaan  (27) and Semtools (28)  packages. 
Where assumptions of univariate normality (assessed by Shapiro Wilks’ test) and 
multivariate normality (assessed by Mardia’s test) were not met, Satorra Bentler corrected 
(robust) indices were used to examine fit of models (29). 
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- Figure 11 - 
 
In line with recommendations, we assessed model fit using the indices below:  
The Standardized Route Mean Square Residual (SRMR) and the Root Mean Square Error of 
                                                 
1 Reprinted from International Journal of Geriatric Psychiatry, Stott et al., Limited validity of the Hospital 
Anxiety and Depression Scale (HADS) in dementia: evidence from a confirmatory factor analysis, Copyright 
(2016) with permission from Wiley. 
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Approximation (RMSEA), have cut-off scores of values <0.05 equating to good fit, <0.08 to 
adequate fit, and > 0.08 to poor fit. The Comparative Fit Index (CFI) and the Tucker Lewis 
Index (TLI) - have cut-off scores of >0.95 equating to good fit, >0.9, to adequate fit and <0.9 
to poor fit. The Bayesian Information Criterion (BIC), is a comparative fit index, with smaller 
values indicating better fitting models, but no cut-off.  
We used information about how well individual items fit within a CFA model to supplement 
fit indices data (25). Items with standardized residual values in excess of 2.58 and high 
modification indices were classified as misspecified (30). We used standardized residuals and 
modification indices to improve (‘re-specify’)  models through specification searching(25) .  
Once a good fitting model was obtained, we examined parameters for interpretability, size 
and statistical significance, and the presence of out of range values (25).  
We assessed obtained factors for concurrent validity with the PANAS using bivariate 
correlations. Where data were normally distributed, we used Pearson’s r and, where not, 
Spearman’s Rank (31). To evaluate hypotheses that the size of correlations between 
particular PANAS subscales and particular HADS subscales would significantly differ from 
one another, we used Steiger tests(32) .  
Measurement invariance of the HADS is necessary if it is to be used to test for differences in 
anxiety and depression across subgroups of carers. Measurement invariance is assumed if 
individuals in different groups with the same levels of the latent construct have the same 
expected raw-score on the measure(17) . To test for measurement invariance of the HADS, 
we split the data into subgroups in terms of four variables that are related to anxiety and/or 
depression in the literature(18, 19); gender, age ( <65 vs ≥  65), kinship (vertical or 
horizontal) and cohabitation status. Following this, we examined the final model derived 
from CFA for the different types of measurement invariance (configural, metric, strong and 
strict) through comparison of progressively more constrained models, with a change in CFI 
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greater than 0.01 taken to indicate change in model fit across constraints and therefore lack of 
invariance between groups(33) .   
To enhance reliability of findings we re-ran (cross-validated) the CFA and measurement 
invariance analyses in the BECCA dataset.  
RESULTS 
Descriptive data for the HADS items are shown in Table 2. Carers in the CSP-RYCT and 
BECCA samples generally reported low levels of depression and anxiety, and consequently 
data was univariate non-normal with positive skew.  Data for original and cross-validation 
samples were skewed with non-normal kurtosis, thus robust CFA indices were used to 
examine model fit in original and cross-validation analyses. 
 
Table 1 showing sample characteristics   
Characteristics/measure Categories N(%)  
Original 
sample 
N(%) Cross-
validation 
sample 
Gender Female 193(68) 149(64) 
 
Ethnicity 
 
White  
 
264(93) 
 
228(99.1) 
 BME~ 20 (7) 2(0.9) 
 
Kinship+ 
 
Horizontal 
 
183 (63.4) 
 
165 (71.7) 
 Vertical 101 (35.6) 65 (28.2) 
 
Education  
 
School leaver:  
 
198(69.7) 
 
- 
 Higher/further education 86(30.3) 85(37.3) 
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Cohabitation status 
 
Cohabiting 
 
224  
 
201(87.5) 
 Not cohabiting 59  29 (12.5) 
 
Dementia subtype of relative 
 
Alzheimer’s disease 
 
131 (46.1)  
 
- 
 Vascular dementia 49 (17.3) - 
 Other 104 (36.6) - 
  Median 
(IQR)  
 
Age (years)   68 (19) 69 (19)* 
Months of caring  48(48) 36 (3)* 
PANAS PA  31.46 (7.37)* - 
PANAS NA (range)   18 (10)  - 
Note: PANAS-PA/NA_Positive and Negative Affect Scale Positive/Negative Affect 
subscales;  
For all demographics and clinical measures N was 284 except for PANAS PA and NA 
(n=265). 
~BME; Black and Minority Ethnic  (individuals of non-white descent) 
+Kinship was defined as horizontal (from the same generation as the person with dementia) 
or vertical (from the generation below the person with dementia)  
- Data was not recorded for the cross-validation sample 
* Mean and SD reported as data normally distributed; 
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Table 2: HADS item descriptive statistics and factor loadings in the best fitting three factor model 
HADS Items arranged by factor in 
final model 
Descriptive statistics for 
HADS items  
Factor loadings and parameters in the 
original analysis (CSP-RYCT data) 
 
 
 Mean(SD) 
original data 
Mean (SD) 
cross-validation 
data  
Estimate 
(SE)* 
Residual  
Variance 
(SE)** 
Communalities*
** 
A
n
x
iety
 
3. I get a sort of frightened 
feeling as if something awful is 
about to happen 
0.81(1) 1 (1) 1 0.29(0.05) 0.71 
9. I get a sort of frightened 
feeling like butterflies in the 
stomach 
0.57(0.76) 0.74(0.77) 0.78 
(0.051) 
0.15(0.02) 0.74 
13. I get sudden feelings of panic 0.75(0.75) 0.79(0.84) 0.72( 
0.051) 
0.19(0.02) 0.65 
D
ep
ressio
n
  
2. I still enjoy the things I used 
to enjoy 
1.03(0.92) 1.37(0.94) 1 0.48(0.05) 0.43 
4. I can laugh and see the funny 
side of things 
0.61(0.76) 0.75(0.77) 0.91  
(091) 
0.29(0.04) 0.51 
6. I feel cheerful 0.62(0.75) 0.63(0.71) 0.99  
(0085) 
0.2(0.02) 0.64 
8. I feel as if I have slowed down 1.34(0.85) 1.65(0.94) 0.77  
(.082) 
0.5(0.05) 0.3 
10. I have lost interest in my 
appearance 
0.63(0.85) 0.67(0.82) 0.78 
(0.11) 
0.51 
(0.06) 
0.3 
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CFA fit and specification searching  
CFA indicated that the three-factor model of anxiety, negative affectivity and depression 
provided the best fit for the data with ‘good fit’ on one index (SRMR) and ‘adequate fit’ on 
the others. It performed better than the one factor model on all indices and better than the 
two-factor model on four indices (RMSEA, SRMR, TLI and BIC).  
12. I look forward with 
enjoyment to things 
0.83(0.9) 1.1(0.85) 0.89 
(0.11) 
0.41(0.05) 0.41 
14. I can enjoy a good book or 
radio or TV program 
0.84(0.84) 0.71(0.88) 1.18 
(0.1) 
0.31(0.04) 0.62 
N
eg
ativ
e A
ffectiv
ity
 
1. I feel tense or 'wound up' 1.16(0.75) 1.17(1.1) 1 0.29(0.03) 0.49 
7. I can sit at ease and feel 
relaxed 
1.15(0.81) 1.39 (0.73) 1.25 
(0.12 
0.23(0.04) 0.66 
11. I feel restless as if I have to 
be on the move 
1.11(0.91) 1.32 (0.91) 1.16 
(0.11) 
0.46(0.05) 0.45 
E
x
clu
d
ed
 
5. Worrying thoughts go 
through my mind 
1.05(0.95) 1.35(0.99) - -  
Note: All HADS items for both samples had significant positive skew and were significantly non- normally 
distributed (Shapiro Wilks, p<0.001)  
*Non standardised parameter estimate - Equivalent to a regression coefficient of the individual prediction of 
the factor by the item, reflecting how much change in the latent variable is associated with one unit change 
in the item  
** Variance in the item unaccounted for by the model;  
***The proportion of the variance in the item that is not accounted for by the model. 
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While it was best performing model, fit was not perfect (as three indices indicated ‘adequate’ 
not ‘good’ fit). Consequently, we conducted specification searching for sources of model 
misspecification in the three-factor model. Modification indices and standardised residuals 
indicated that item five (part of the negative affectivity factor) had the highest modification 
index (50.15) indicating significant cross-loadings onto the anxiety factor. Item five also had 
the highest single standardized residual (9.3) and highest number of standardized residuals 
(3) above 2.58. In addition to this evidence of substantial misspecification, item five has 
previously been empirically and conceptually associated with an ‘anxiety’ factor rather than a 
negative affectivity factor (25).  Consequently we re-ran the model with item five removed. 
This significantly improved model fit with three fit indices (SRMR, CFI and TLI) now 
indicating a good fit to the data. Having identified this best fitting model, examination of 
non-standardized parameter estimates (detailed in table 2) revealed that all items had highly 
significant loadings onto their respective factors in the expected direction. Furthermore, the 
correlations between latent factors of anxiety and depression (0.32) anxiety and negative 
affectivity (0.29) and depression and negative affectivity (0.25) were relatively low (<0.5), 
providing further indication that a multifactorial solution is appropriate(30).  
Cross-validation in the BECCA data confirmed initial results. The three-factor model was 
again the best fitting model (χ2 (robust) = 137.86, 74 df; SRMR = 0.055; CFI = 94; TLI = 
0.93; RMSEA = 0.065 (90%CI 0.048-0.082)) although fit was not quite as good as in the 
CSP-RYCT data with all indices of fit adequate. Also, similarly to the original data, the 
highest modification index (20.18) and most standardized residuals above 2.58 were 
associated with item five and removal of this item improved values on RMSEA and SRMR 
(χ2 (robust) = 112.16, 78 df; SRMR = 0.052; CFI = 94; TLI = 0.93; RMSEA = 0.059 (90%CI 
0.042-0.076)) supporting the lack of utility of this item in this group.   
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Internal consistency and Concurrent validity  
Internal consistency of the depression (=0.85) and anxiety scales (=0.87) was good, with 
internal consistency of the negative affectivity scale adequate (=0.77). As expected, 
correlations between scores on all HADS-scales and those on PANAS-PA/NA were large, 
significant and in the expected direction. In line with previous literature(22), the HADS 
depression scale had a significantly larger negative correlation with PANAS-PA than either 
the HADS anxiety or HADS negative affectivity subscales (t (264)= 5.76 and 5.15 
respectively, p<0.001). Also in line with expectations, the HADS negative affectivity scale 
had a significantly larger correlation with PANAS-NA than the HADS depression subscale (t 
Table 3. Fit indices of original and respecified versions of one factor, two factor and three 
factor models 
Model 
χ2 
(robust) 
Df Srmr 
Cfi TLI Rmsea  (90% CI) BIC 
One factor  342.68 77 0.071 
0.81 0.775 0.126(0.112-0.140) 8465.8 
Two factor 
original 
224.2 76 0.066 
0.9 0.88 0.093(0.079-0.107) 8438.1 
Three factor 
original 
162.61 74 0.049 0.94 0.93 0.072(0.057-0.077) 8370.37 
Three factor 
without item 5  
112.64 62 0.041 0.96 0.95 0.06(0.042-0.077)  7686.89 
Note: SRMR _ standardized root mean residual ( <0.05 suggests good fit, <0.08 suggests 
adequate fit, >0.08 suggests poor fit); CFI _ comparative fit index (>0.95 suggests good fit, 
>0.9 suggests adequate fit, <0.9 suggests poor fit); TLI_tucker Lewis Index (> 0.95 indicates 
good fit, >0.9 suggests adequate fit, <0.9 suggests poor fit ); RMSEA _ root mean square 
error of approximation (< 0.05 is good fit,  <0.08 is adequate fit, >0.08 is poor fit) 
CI_confidence interval; BIC_ Bayesian information criterion.  
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(264)=2.62, p<0.01). The one finding counter to expectations was that the PANAS-NA 
correlation with the HADS negative affectivity scale was not larger than that with the HADS-
anxiety scale. It is notable, however, that unlike HADS-negative affectivity, HADS anxiety 
did not correlate significantly more with PANAS-NA than HADS depression.  
 
Table 4: Correlations of HADS and PANAS subscales  
 PANAS-Negative affect  PANAS-Positive Affect  
HADS Anxiety 0.64   -0.37         
HADS NA (with item 5 missing) 0.69    -0.45       
HADS depression 0.57  -0.65        
Note; All correlations significant at P<0.001(p values corrected for multiple comparisons using 
Holm’s method(29). Degrees of freedom for all correlations = 263 (N=265). 
 
Measurement invariance  
We assessed measurement invariance of the best fitting structure (three factors, item five 
removed) across groups differing on important variables having first divided the CSP-RYCT 
and BECCA data divided into subgroups according to gender, age (<65 vs ≥65 ratio = 
110:175 and 84:146 respectively), cohabitation status (cohabiting or not cohabiting) and 
kinship status (horizontal or vertical). With the exception of age, numbers and proportions in 
each subgroup in original and cross-validation samples are given in Table 1. The results of 
the analysis of the different types of invariance (configural, metric, strong and strict) in the 
CSP-RYCT data are shown in Table 3. Configural invariance findings indicate that on one 
index (CFI values above cut-off) but only just on another (RMSEA values at cut-off) the 
form of factor structure (three factors, item five removed) determined in the whole group 
applies across subgroups. Our findings suggest metric invariance across subgroups. This 
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implies that a unit change in the value of HADS item raw scores is related to the same 
amount of change in a latent factor score in all subgroups. The strong invariance assumption 
is met for gender, kinship and cohabitation status but not age. This indicates that for gender, 
kinship and cohabitation status but not age, the intercepts of items (their value when the latent 
variable is at 0) are similar across subgroups. The lack of strong invariance across groups in 
age implies that there may be a systematic response bias with adults in different age groups 
systematically endorsing different item scores on the HADS independent of their underlying 
levels of anxiety, depression or negative affectivity.   
Table 5. Series of model comparisons to test measurement invariance of three factor model with item 5 
removed in original (CSP-RYCT) data. 
Subgrouping Invariance 
type 
χ2 (∆χ2) DF 
(∆DF) 
∆p CFI(∆CFI) RMSEA 
Gender Configural 241.68 124 N/A 0.93 0082 
Metric (9.75) (10) 0.46 (<0.0001) NA 
Strong (13.32) (10) 0.21 (0.002) NA 
Strict (20.71) (13) 0.078 (0.006) NA 
 
Age  Configural 230.11 124  0.94 0.078 
Metric 19.75 10 (0.032) (0.006) NA 
Strong 35.40 10 (0.0001) (0.014)* NA 
Strict 23.6 13 (0.035) (0.001) NA 
Kinship Configural 232.86 124  0.94 0.079 
Metric 16.44 10 (0.088) (0.004) NA 
Strong 27.62 10 (0.002) (0.01) NA 
Strict 18.07 13 (0.15) (0.002) NA 
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Cohabitation 
status 
Configural 224.21 124  0.94 0.076 
Metric 13.61 10 (0.19) (0.002) NA 
Strong 25.15 10 (0.005) (0.009) NA 
Strict 0.82 13 (0.97) (0.001) NA 
Note: For configural invariance fit indices CFI _ comparative fit index (>0.95 suggests good fit, >0.9 suggests 
adequate fit, <0.9 suggests poor fit), RMSEA _ root mean square error of approximation (< 0.05 is good fit,  
<0.08 is adequate fit, >0.08 is poor fit). For all other invariance types, ΔCFI < 0.01 implies that the invariance 
assumption still holds. * indicates that invariance assumption is not met according to these criteria. 
 
 
Associations between measurement invariance categories 
To further explore why age was measurement variant and other variables were not when age 
is commonly related to cohabitation status, kinship and gender in dementia carers, we 
examined association of age with these variables in our sample. Results are given in Table 6. 
All variables were significantly related to age. The small and medium (rather than large) 
effect sizes of the associations with gender and cohabitation perhaps explain the difference 
between gender, cohabitation and age in invariance findings; the large effect size for 
association with kinship perhaps explains why the pattern of invariance results for kinship 
was very similar to age, but just failed to cross the significance threshold for strong 
invariance.  
Table 6 showing relationship between measurement invariance categories  
 Gender Kinship  Cohabitation  
2 value in original sample 12.187 141.56 81.47 
Effect size (Phi) in original sample 0.21 0.71 0.54 
2  value  in cross validation sample 11.03 84.71 26.2 
Effect size (Phi)  in cross validation sample 0.22 0.61 0.34 
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Note:  All  2 values significant at p<0.001; degrees of freedom for all tests were 1; the 
direction of the above results for both samples were that women are more likely to be older 
than men; cohabitees are likely to be older than nom-cohabitees, and horizontal-kinship 
carers are more likely to be older than vertical-Kinship carers; Effect size categories of 0.1 = 
small effect, 0.3 = medium effect and 0.5 = large effect were used for interpretation (34). 
(34)- 
 
Cross-validation of measurement invariance analysis 
Measurement invariance analysis on the BECCA data supported the original analysis findings 
for gender and kinship, which again exhibited measurement invariance at all levels, (RMSEA 
always <0.08, CFI > 0.9, and ∆CFI never >0.01) and age, which exhibited measurement 
invariance at some but not other levels (although it exhibited strict rather than strong 
measurement variance in this second analysis). However, unlike the original results, 
configural invariance was not demonstrated for cohabitation status (CFI = 0.87 and RMSEA 
= 0.93) thus measurement invariance is not reliably demonstrated for this variable.  
 
CONCLUSIONS 
We are the first to evaluate the utility of the HADS in carets of people with dementia.  We 
found that, in this group, the HADS is best interpreted in terms of three factors; depression, 
anxiety and negative affectivity. The depression scale can be interpreted as originally 
intended (6). This supports the results of recent large clinical trials, which have either used 
the HADS depression scale as a primary outcome(8) or shown improvement in HADS 
depression caseness (4). However, the lack of utility of the original anxiety scale suggests  
that current clinical practice recommendations (7) might be revisited. Future clinical trials 
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should use a three-factor interpretation of the HADS rather than the currently used one or two 
factor models, with depression rather than anxiety or distress used as the primary outcome.   
Cross-validation 
Our finding of three factors is supported by cross-validation in a separate sample and 
preliminary concurrent validity findings, which were as expected (22) as well as the good to 
adequate internal consistency of scales, despite limited item numbers which can depress 
alpha values (35). Our finding of three factors is also in line with research examining the 
HADS in some other populations not defined by their mental health status (9) 
Measurement of distress and anxiety 
Our results do not support the use of the HADS as a single factor ‘distress’ measure in carers 
of people with dementia. This structure fits the data least well. The use of the original HADS 
anxiety scale, is also not supported, rather our findings support the tripartite interpretation of 
Dunbar.et al. (30) which splits the anxiety subscale into ‘anxiety’ and ‘negative affectivity’. 
However, for pragmatic clinical use,  this interpretation of anxiety and negative affectivity is 
complex(16) with a lack of a simple way to  understand range of symptomatology and 
caseness(9, 36) . Furthermore, our finding that the best fit was obtained when one item (item 
five) was removed from the negative affectivity scale, while in line with the literature(36) , 
and cross-validated in our study,  reduces the size of the negative affectivity and anxiety 
subscales to three items each. This is likely to impact on content validity (10) with potential 
impact on screening sensitivity. Consequently, we suggest that use of the HADS anxiety 
/negative affectivity scales in carers while empirically justified, is clinically limited.  
Can the HADS be used to measure across carer subgroups?  
There is significant heterogeneity in the carer population and variation in characteristics such 
as age, gender, kinship and cohabitation status is related to anxiety or depression(18, 19). Our 
measurement invariance data suggest that, in a dementia carer population, differences in 
HADS subscale scores between older (≥65) and younger (< 65) adults may be 
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uninterpretable. Specifically, there may be a systematic bias in the way in which different age 
groups respond to the HADS that is not to do with differences in anxiety, depression or 
negative affectivity(17). Consequently, research using the HADS to examine variations in 
anxiety and depression between those of different age groups will be difficult to understand. 
In clinical work, where normative reference groups differ in age to the carer, HADS scores 
may be difficult to meaningfully interpret. As age and kinship are closely associated, 
interpretation across kinship groups may also be problematic (although this was ambiguous in 
our data). This difficulty in interpretation may also be the case for cohabitation status as 
measurement invariance findings from the original analysis were not replicated in the cross-
validation sample. As measurement invariance is clearly adequate across kinship and gender, 
comparisons in HADS scores across this variable can be meaningfully conducted.   
Strengths and limitations 
This is the first study to examine the utility and interpretability of the HADS in carers of 
people with dementia specifically. We assessed several international consensus defined areas 
of health outcome measurement quality(10) including structural validity, reliability, and 
construct validity through hypothesis testing. Particular strengths are use of a robust CFA 
approach, and assessment of measurement invariance, an important (37) and often 
overlooked element of validity. There are limitations. Lack of assessment of concurrent, 
discriminant and criterion validity are important issues given HADS usage and future 
research is needed. However, assessment of these validity aspects is in part dependent on 
understanding factor structure and when factor structure has been established in a population, 
these validity aspects  may be less population variant (21). Consequently, given our support 
for the original HADS depression scale, future carer research and clinical practice could be 
preliminarily informed by the well-established depression scale criterion validity data from 
other populations. The mean score on HADS items was low in both samples. Future work 
  23 
should examine this measure in samples where there is more variance and higher levels of 
depression and anxiety. Ethnicity may influence reporting of depression in this group and the 
limited numbers of Black and Minority Ethnic participants in our sample meant analysis of 
this was not possible. As our samples came from randomized controlled trials, our 
participants may differ from clinical populations, potentially limiting generalisability.  
Although we evaluated the most frequently proposed structures in the literature, not all 
potential HADS structures were considered. Future research should examine the bi-factor 
structure (38) and the impact of measurement artefacts (39). Finally, item Response Theory 
studies should be conducted in this population as these provide strong evidence of latent 
variable structure, tend to support one factor structures and are more generalizable from the 
sample to the population(9). 
Implications 
The HADS is a measure widely used and recommended in dementia carer research and 
practice. It is best interpreted as measuring three factors; depression, anxiety and negative 
affectivity. The use of the depression subscale is supported. However, clinical practice 
recommendations, currently based on a two-factor model should perhaps be revisited, with 
further research needed. Future trials should focus on HADS depression not anxiety or 
distress as an outcome measure. The HADS can be used to compare carers varying in gender 
and possibly kinship, but may not be accurate in comparing those varying in age or 
cohabitation status.  These results run counter to the use of the HADS in carers of people with 
dementia thus far, and have significant implications for future research and practice with this 
widely used and recommended measure. 
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Figure legend:  
‘Figure 1 Showing schematics of 1 factor model of Razavi, 2 factor model of Zigmond and 
Snaith and 3 factor model of Dunbar.’ 
 
 
